Navigating Neuropsychology

There is a need for neuropsychologists in an inpatient rehab setting and throughout follow-up care for children who are resuscitated after experiencing a cardiac arrest. Today, we talk with Beth Slomine, Ph.D., ABPP-CN, about the risks and benefits associated with therapeutic hypothermia for these children, and her involvement in the THAPCA multi-site trial. Show notes are available at www.NavNeuro.com/49 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

The U.S. has the largest annual incidence of new human immunodeficiency virus (HIV) diagnoses among high-income nations. This is relevant for neuropsychologists because individuals with HIV develop a spectrum of cognitive, motor, and/or mood problems collectively known as HIV-Associated Neurocognitive Disorder (HAND). In this episode, we talk with April Thames, Ph.D., about cross-cultural considerations and age-related cognitive decline in HIV. Show notes are available at www.NavNeuro.com/48 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

Previously, test score labeling has varied across practitioners, leading to discrepancies in the interpretation and communication of neuropsychological assessment results. The American Academy of Clinical Neuropsychology (AACN) formed a consensus conference to address this concern, charged with establishing a uniform test score labeling system. Today we talk with co-chair Tom Guilmette, Ph.D., ABPP-CN, about the new system and the hope that all neuropsychologists will adopt it. Show notes are available at www.NavNeuro.com/47 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credit for listening to episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

As states and counties begin lifting stay-at-home orders, many neuropsychologists are considering resuming their in-person clinical services. However, there is no clear roadmap to guide reopening and ensure patient and provider safety. Today we talk with Laura Lacritz, Ph.D., ABPP-CN, who is on the frontlines of returning to in-person neuropsychological evaluations in the context of the COVID-19 pandemic. Show notes are available at www.NavNeuro.com/46 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credit for listening to episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

Technology is changing at an ever-increasing rate, warranting the need to stay updated with current advancements. Today we talk with Raeanne Moore, Ph.D., about using ecological momentary assessment (EMA), mobile cognitive testing (MCT), and wearable technology to assess cognitive and emotional functioning in a real-world environment. We also discuss how these assistive technologies compare to traditional paper-and-pencil cognitive measures. Show notes are available at www.NavNeuro.com/45 _________________ If you'd like to support the show, here are a few easy ways: 1) Get APA-approved CE credits for listening to select episodes: www.NavNeuro.com/INS 2) Tell your friends and colleagues about it 3) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 4) Check out our book Becoming a Neuropsychologist, and leave it an Amazon rating Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

In our second Neuropsych Bite, we talked with Joel Kamper, Ph.D., ABPP-CN, about Creutzfeldt-Jakob Disease (CJD), a rare condition that leads to rapid decline in cognitive, motor, sensory, and behavioral functioning. This is the first of a series on rare neurological disorders. Show notes are available at www.NavNeuro.com/44 _________________ If you'd like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

In our first Neuropsych Bite, we talked with Dr. Maggie Lanca about advocacy for neuropsychology at both the state and federal level. She also discusses her recent advocacy efforts for teleneuropsychology in response to the COVID-19 pandemic as President of the Massachusetts Psychological Association, as well as her advocacy work as a delegate of the Interorganizational Practice Committee (IOPC). Show notes are available at www.NavNeuro.com/43 _________________ If you'd like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

We talked with Joel Kamper, Ph.D., ABPP-CN, regarding licensure requirements to practice as a clinical psychologist, and how these requirements vary across states and provinces. In addition to providing an overview of the Examination for Professional Practice in Psychology (EPPP), Joel discusses his role in the development of the EPPP Part 2-Skills. Show notes are available at www.NavNeuro.com/42 _________________ If you'd like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

The COVID-19 pandemic is impacting every corner of our world, and neuropsychology is certainly not immune from its effects. In particular, many neuropsychological clinics have temporarily shut down operations in response to the widespread call for social distancing. With this as the backdrop, we speak with Munro Cullum, Ph.D., ABPP-CN, about teleneuropsychology and telemedicine in general. We distinguish between pre-COVID-19 teleneuropsychological evaluations, conducted in clinics and other controlled environments, and the current push for home-to-home teleneuropsychology. We then dive into the details of teleneuropsychology, including topics such as research evidence for feasibility, reliability, and validity of this methodology, patient acceptability, environmental challenges, patient privacy and informed consent, and trainee clinical hours, among others. Throughout the interview, Dr. Cullum summarizes the current literature and provides advice, tips, and guidance for interested researchers and clinicians. Show notes are available at www.NavNeuro.com/41 _________________ If you'd like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]

We brought Monica Rivera Mindt, Ph.D., ABPP-CN, back on the podcast to discuss the cognitive effects of opioid use (both licit and illicit). We discuss the history of the opioid epidemic in the U.S., the neurobiology of opioids, and common treatments for opioid use disorder. Show notes are available at www.NavNeuro.com/40 _________________ If you'd like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an Apple Podcasts rating/review: www.NavNeuro.com/itunes 3) Contribute to the discussion in the comments section of the website (click the episode link listed above) or on Twitter (@NavNeuro) Thanks for listening, and join us next time as we continue to navigate the brain and behavior! [Note: This podcast and all linked content is intended for general educational purposes only and does not constitute the practice of psychology or any other professional healthcare advice and services. No professional relationship is formed between hosts and listeners. All content is to be used at listeners' own risk. Users should always seek appropriate medical and psychological care from their licensed healthcare provider.]